The Claim
Plasma neurofilament light chain levels become abnormal approximately 5 years before the clinical onset of mild cognitive impairment in individuals who later develop Alzheimer’s disease, indicating that this biomarker reflects later-stage neurodegeneration rather than the initial pathological events.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people who will eventually develop Alzheimer’s disease, levels of neurofilament light chain in the blood rise about five years before they show signs of memory problems, and this change is linked to advanced nerve cell damage, not the earliest disease triggers.
See the scientific wording
Neurofilament light chain (NfL) in plasma becomes abnormal approximately 5 years before clinical onset of mild cognitive impairment in individuals who develop Alzheimer’s disease, suggesting it reflects later-stage neurodegeneration rather than early pathological initiation.
When nerve fibers in the brain start to break down, their internal scaffolding breaks apart and spills into the surrounding fluid, which then enters the bloodstream. This spill happens close to when memory problems begin, not at the very start of brain changes.
What the research says
1 studyStudy: Plasma biomarker trajectories across Alzheimer’s clinical onset: a 17-year prospective study
This study found that a blood marker called NfL only starts to rise about 5 years before people begin having memory problems, while other signs of Alzheimer’s show up much earlier — meaning NfL tracks brain damage that happens closer to when symptoms appear, not the very first disease changes.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.